Fluconazol Olainfarm

Quick links

Choose a section

Quick links to important sections

Advertisements

Fluconazol Olainfarm

Advertisements

Overview of Fluconazol Olainfarm

Property Description
Active Ingredient Fluconazole
Pharmacological Class Systemic Antifungal Agent; Triazole Derivative
Forms Capsules, Oral Suspension, IV Solution
Common Use (General) Treating and preventing fungal infections
Origin Synthetic

Classification and Core Identity

Fluconazole is a synthetic, single-ingredient medicinal substance categorized as a systemic antifungal agent, specifically belonging to the triazole derivative class. This compound is engineered to address fungal and yeast pathogens throughout the body. The specific product, Fluconazol Olainfarm, derives its name from the manufacturer, Olainfarm, highlighting its origin from a European pharmaceutical producer. Fluconazole is a well-established drug used for the treatment of various fungal infections.


Composition, Origin, and Preparation Forms

The medicine is composed solely of the active ingredient Fluconazole, contained within an inert pharmaceutical base suitable for delivery. As a product of synthetic origin, Fluconazol Olainfarm is available in several dosage forms, including oral capsules (hard gelatin), an oral suspension, and a sterile solution for intravenous use (IV infusion). This manufacturing approach provides flexibility in administration, ensuring the drug can reach the infection site efficiently. The availability of both oral and intravenous preparations makes it suitable for both short-term and sustained systemic therapy.


The High-Level Action of Fluconazole

The general purpose of this medication is to control and limit the spread of fungal and yeast infections throughout the body. Fluconazole achieves this by exerting a fungistatic action, which means it interferes with the essential building blocks required to maintain the stability of the fungal cellular membrane. By selectively targeting and disrupting a critical enzyme involved in this structural process, the medication effectively prevents the continuous proliferation of the infectious agents. This action assists the body in managing and resolving the condition caused by fungal overgrowth.

Regulatory References

  1. Systemic Antifungal Agents Overview (NIH StatPearls)
  2. Fluconazole Indications (NIH StatPearls)
  3. MedlinePlus
  4. Fluconazole Mechanism and Efficacy (NIH StatPearls)
  5. Fluconazole Fungistatic Action (NIH StatPearls)
  6. Fluconazole Mechanism of Action (NIH StatPearls)
Advertisements

What side effects are possible with Fluconazol Olainfarm?

Possible Side Effects and Safety Information

The safety profile for Fluconazole is documented by government regulatory bodies, classifying adverse reactions primarily by frequency and the body system affected. These classifications reflect how official documents organize the medicine’s risks.


Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized using standardized terminology. Common reactions (affecting 1 to 10 users in 100) often involve the gastrointestinal system (nausea, vomiting, diarrhoea, abdominal pain) and the nervous system (headache). They also include increases in certain liver enzymes, such as ALT and AST. Uncommon reactions include anaemia, seizures, dizziness, and skin effects like urticaria and itching. Rare reactions (affecting less than 1 in 1,000 users) include severe conditions affecting the blood, heart, and liver.


Serious Safety Considerations

Regulatory documentation highlights rare, serious adverse reactions that concern specific physiological systems:

  • Hepatic Toxicity: Rare cases of severe liver injury, including hepatic failure, have been documented, generally reported as reversible upon discontinuation.
  • Dermatological Reactions: Rare, severe skin disorders, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, are formally listed.
  • Cardiac Events: Rare occurrences of QT prolongation and Torsade de pointes are documented, particularly in seriously ill patients with underlying risk factors.

Population-Specific Safety Notes

Official safety notes advise caution for specific patient groups. Individuals with impaired renal function require consideration because the medicine is primarily excreted by the kidneys. Caution is also specified for patients with existing hepatic dysfunction and those with cardiac risk factors that could increase the likelihood of rare heart events. Additionally, specific safety statements apply to the chronic, high-dose use of fluconazole during pregnancy.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations and Severity

A documented overdose of Fluconazol Olainfarm can result in severe systemic manifestations, primarily affecting the central nervous system (CNS) and cardiovascular system. Officially reported CNS symptoms include hallucinations and pronounced paranoid behavior (fearfulness or extreme suspiciousness), alongside a documented risk of seizures associated with high systemic concentrations.

The most serious concerns involve cardiotoxicity, specifically the potential for QT prolongation on the electrocardiogram, which carries the risk of a life-threatening ventricular arrhythmia known as Torsade de Pointes. These severe outcomes mandate that individuals who suspect an overdose must seek immediate medical attention and contact emergency services.

Management and Risk Factors

Management procedures involve instituting symptomatic and supportive treatment. As no specific antidote is known, regulatory documents describe methods for drug elimination, such as hemodialysis, which is documented to reduce plasma concentrations by approximately 50% in a three-hour session. A critical consideration for toxicity risk is impaired renal function, as the drug is primarily cleared by the kidneys, and reduced function significantly increases the potential for drug accumulation.

Advertisements

Therapeutic Uses of Fluconazol Olainfarm

What Fluconazol Olainfarm Treats: Main Uses and Benefits

Fluconazol Olainfarm may be part of symptomatic management for serious conditions that have entered the bloodstream (candidemia) and sensitive areas like the brain and spine (cryptococcal meningitis). It is also commonly used in conditions presenting with localized discomfort on mucosal tissues, such as yeast infections of the mouth, throat, esophagus, vagina, and for fungal infections of the skin and nails. It is relevant in the management of systemic candidiasis, particularly in vulnerable groups like immunocompromised patients.


Quick Fact: Focus on Localized Symptom Domains

The medication helps manage symptom clusters characterized by burning, soreness, itching, and difficulty swallowing in situations where patients experience acute manifestations.


The medicine is commonly used as suppressive therapy to support efforts to reduce the frequency of symptomatic episodes of recurrent fungal conditions or for prophylactic support during periods of high immunological stress. This intervention provides supportive relief from acute local discomfort, which contributes to easing the symptom burden and supports general well-being during symptomatic phases.

“This therapy is relevant for easing distress and assisting with functional stability during difficult episodes.”

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Populations for whom use is contraindicated:

  • Patients with documented hypersensitivity to fluconazole, related azole substances, or any product excipients.
  • Patients receiving co-administration of cisapride, astemizole, pimozide, quinidine, or erythromycin.
  • Patients receiving high-dose fluconazole (400 mg/day or greater) while concurrently taking terfenadine.

Age-related eligibility rules:

  • The medicine is approved for use in adults and older adults. For all pediatric ages, including newborns, use is established for appropriate indications, but requires monitoring due to age-dependent drug clearance.

Condition-specific eligibility rules:

  • Use is conditional and requires caution for patients with impaired renal function or liver dysfunction.
  • Caution is also required for patients with potentially proarrhythmic conditions, such as structural heart disease or abnormal blood electrolyte levels.

Pregnancy and lactation eligibility status:

  • Use in pregnancy is generally not recommended unless necessary for serious infections. High-dose or prolonged regimens are associated with documented risks and should be avoided. Use of a single low dose during lactation is generally acceptable.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fluconazole may alter the concentration of many co-administered medicinal products. This interaction profile is primarily due to fluconazole’s established ability to inhibit certain liver enzymes, specifically Cytochrome P450 (CYP) enzymes, including CYP2C9 and CYP3A4, which are involved in the metabolism of numerous other drugs.

Combinations Not Permitted:

The co-administration of fluconazole is prohibited with specific medicines due to the high risk of serious cardiac events, including Cisapride, Astemizole, Pimozide, Quinidine, and Erythromycin. Co-administration with Terfenadine at daily doses of 400 mg or higher is also prohibited.

Interactions Requiring Precaution:

Fluconazole increases the plasma concentration of many medicines by inhibiting their metabolism. Medicines affected include certain immunosuppressants (e.g., Ciclosporin, Tacrolimus), anticoagulants (e.g., Warfarin), oral sulfonylureas, short-acting benzodiazepines (e.g., Midazolam), statins, and antiepileptics (e.g., Phenytoin). The concurrent use of these combinations may require clinical monitoring to manage potential concentration increases of the co-administered drug.

Conversely, other medicinal products can alter the concentration of fluconazole. For example, co-administration with Rifampicin can significantly decrease fluconazole exposure, while Hydrochlorothiazide can cause an increase in fluconazole concentration. The absorption of fluconazole is not significantly affected by food.

Advertisements

Mechanism of Action

The mechanism of Fluconazole involves interference with the essential structures of fungal cells. The action is fungistatic, meaning it results in the suppression of fungal growth and replication.

Inhibiting the Fungal Cell's Enzyme Machinery

Fluconazole selectively engages the enzyme lanosterol 14-alpha-demethylase (CYP51) found within the fungal cell. By acting as an inhibitor, the drug blocks the enzyme's function, preventing the fungal metabolic pathway from synthesizing ergosterol. This is the critical sterol component required for building and maintaining the fungal cell membrane, and the mechanism exhibits high selectivity for the fungal enzyme.

Compromising Fungal Membrane Integrity

The resulting lack of essential ergosterol and the subsequent accumulation of abnormal, toxic sterols lead to the structural disorganization of the fungal cell membrane. This molecular change impairs the membrane's fluidity and permeability, resulting in the malfunction of membrane-bound cellular processes. The physiological consequence of this structural failure is the arrested proliferation of the fungus.

Advertisements

Dosage and Administration Information

How to Use Fluconazol Olainfarm

Fluconazole is administered systemically and is available in two principal forms: for oral use (capsules or suspension) and as a solution for intravenous (IV) infusion. The daily dosage is the same for both routes due to the drug’s high oral absorption, allowing for transition between hospital and outpatient care.

Most multi-day regimens follow a once-daily administration pattern. To rapidly achieve stable concentrations, treatment often begins with a loading dose on Day 1, which is typically double the subsequent daily maintenance dose. Conversely, certain acute conditions may utilize a single oral dose of 150 mg, while others require intermittent weekly use over several months for relapse prevention. Fluconazole may be taken with or without food as the timing of intake does not significantly affect its efficacy.

Administration Requirements

Area of Instruction Procedural Guideline
Dose Adjustment Dosing must be adjusted for patients with renal impairment (low creatinine clearance).
Pediatric Use Doses are strictly weight-based and may require extended intervals in neonates.
IV Infusion Rate Intravenous solution should be administered slowly, typically not exceeding a rate of 200 mg per hour.
Oral Suspension The liquid requires accurate measurement using a calibrated device after reconstitution.

These standardized procedures establish the framework for administering the medicine.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Fluconazol Olainfarm

This overview describes the types of clinical research and studies that have been conducted on the active substance, fluconazole. The research describes how the medicine has been observed in clinical studies in different groups of patients and for specific conditions. This summary strictly reflects the scientific evidence landscape and does not offer individual medical advice or treatment recommendations.

Research Evidence for Invasive Systemic Fungal Infections

Research for serious infections, such as those of the bloodstream (Candidemia) or central nervous system (Cryptococcal Meningitis), primarily involves Randomized Controlled Trials (RCTs). These studies examined treatment structures for complex diseases, which are characterized by systemic or functional imbalance. Researchers monitored outcomes related to pathogen clearance and overall survival over defined time intervals.

Findings from these trials describe patterns related to the duration of pathogen clearance observed in the study populations. Comparative studies reported survival measurements for treatment with fluconazole compared to other defined treatment structures or combination regimens.

Research Evidence for Mucosal and Localized Infections

The research on fungal infections affecting mucosal tissues—such as the mouth, throat, esophagus, or vagina—was evaluated in Comparative Trials. These studies examined short-term or episodic symptom patterns that cause localized discomfort. Primary outcomes monitored included outcomes related to physical discomfort (symptom resolution) and laboratory evidence of pathogen clearance.

Studies report how symptoms evolved in the observed populations. Research explores responses over defined time intervals, extending up to 12 months for nail infections to track outcomes reflecting nail integrity and health.

What is Still Uncertain About the Research Landscape

The existing evidence base highlights areas where additional research is needed. Specifically, certainty remains low regarding the consistency of an overall survival benefit across all prophylactic studies. Comparative evidence is lacking in some areas, such as the full long-term risk of emergence of resistance in certain fungal species following repeated use. Research is ongoing to address these documented data gaps and provide further context on patterns observed in the studies.

Key Studies & References A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems (Esophageal Candidiasis) - ClinicalTrials.gov (NCT00002339)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Fluconazol Olainfarm (FAQ)


Q: How quickly should I expect Fluconazol Olainfarm to start working?

A: Official information on how the medicine is absorbed states that peak concentrations in the bloodstream are typically reached within 1 to 2 hours after taking an oral dose. For treatment regimens involving multiple doses, stable drug levels, which are necessary for the full effect, are generally achieved within about 5 to 10 days, or by the second day if a higher loading dose is administered initially.


Q: Why is Fluconazol Olainfarm packaged in different strengths?

A: Fluconazole is manufactured in various capsule strengths, such as 50 mg, 100 mg, 150 mg, and 200 mg, to accommodate the wide range of approved conditions it treats. Official prescribing information outlines different dosing needs for short-term local infections versus long-term management of serious systemic infections.


Q: How long does Fluconazol Olainfarm stay in your system after the last dose?

A: Fluconazole has a long elimination half-life, meaning it takes a relatively long time for the body to remove it. Official pharmacokinetics data indicates the half-life is approximately 30 hours in healthy individuals. Based on this, the drug is expected to be almost entirely eliminated from the system within several days after the last dose.


Q: Does Fluconazol Olainfarm work for skin fungal infections too?

A: Yes, regulatory documents indicate that Fluconazole is approved for treating various fungal infections of the skin, collectively known as dermatophytoses. These include infections such as athlete's foot (Tinea pedis), ringworm (Tinea corporis), jock itch (Tinea cruris), and Tinea versicolor, as well as certain types of skin Candida infections.


Q: What kind of infections does Fluconazol Olainfarm treat besides yeast infections?

A: In addition to common yeast infections (Candidiasis), the medicine is officially indicated for treating serious infections caused by other fungi. These include Cryptococcosis, such as cryptococcal meningitis (an infection of the brain and spinal cord lining), and various severe systemic (body-wide) infections caused by Candida.


Q: What happens if I miss a dose of Fluconazol Olainfarm?

A: Regulatory patient information outlines that if a dose is missed for a once-daily regimen, the standard guidance is to take it when remembered, unless it is near the next dose time. For precise instruction on a specific regimen, patients should always refer to the instructions in the patient leaflet or provided by their healthcare professional.


Q: Why do some people need a single dose of Fluconazol Olainfarm and others need multiple?

A: The required treatment course length is determined by the specific type and severity of the fungal infection. For instance, uncomplicated vaginal candidiasis is often treated effectively with a single oral dose. In contrast, serious, systemic infections or prevention of relapse requires a multi-day or long-term regimen, as outlined in official dosage guidelines.


Q: Is Fluconazol Olainfarm commonly used for candida infections?

A: Yes, Fluconazole is a primary antifungal used to treat infections caused by Candida species, which are a type of yeast. Regulatory indications cover a range of these infections, including those affecting the mouth and throat (oropharyngeal), the esophagus, the vagina, and serious infections spread throughout the body (systemic candidiasis).


Q: What are the signs that Fluconazol Olainfarm is actually working?

A: Efficacy is assessed based on the resolution of the patient’s clinical symptoms, which are monitored during the course of treatment. Official studies track outcomes such as the resolution of physical discomfort, the clearance of physical lesions, or the reduction of fever. For certain infections, success is also confirmed by laboratory evidence showing the clearance of the fungus.


Q: Can Fluconazol Olainfarm cause a metallic taste?

A: Yes, official safety information documents that some users may experience a change in taste. This adverse reaction is described using terms like 'taste perversion' or an 'unpleasant taste,' which some individuals may interpret as a metallic taste.


Q: Can Fluconazol Olainfarm cause dry mouth?

A: The official documentation on adverse reactions does list dry mouth (also called xerostomia) as an uncommon adverse effect. This means it has been reported by a smaller percentage of individuals during clinical trials and post-marketing experience.


Q: Can Fluconazol Olainfarm interfere with my sleep?

A: Official safety profiles note that the medicine can cause uncommon adverse effects related to the nervous system, such as somnolence (drowsiness) and dizziness. These are documented in the safety profile of the medication.


Q: Does Fluconazol Olainfarm have any effect on blood sugar levels?

A: Fluconazole may indirectly affect blood sugar levels by interacting with other medicines. Regulatory information states that it can increase the concentration of oral sulfonylureas—a class of drugs used to treat diabetes—by slowing their breakdown. This interaction may necessitate adjustments or monitoring when used concurrently with these medications.


Q: Is there a time of day that is best for taking Fluconazol Olainfarm?

A: Official patient information often suggests taking once-daily medication at the same time each day to ensure consistent levels of the drug in the body. However, the timing itself is flexible, as regulatory documents confirm that it may be taken at any time and with or without food.


Q: How should Fluconazol Olainfarm be stored?

A: All forms of Fluconazole, including the tablets and IV solution, must be kept at a controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It is also specifically noted in the official instructions that the liquid preparations, such as the IV solution and suspension, must be protected from freezing to maintain their stability.


Q: Can Fluconazol Olainfarm cause temporary hair loss?

A: Yes, official safety information reports that alopecia (hair loss or thinning) has been observed as an uncommon adverse reaction during post-marketing use of fluconazole. This effect is documented in the regulatory safety profile of the medication.


Q: Are there studies on Fluconazol Olainfarm's effectiveness against different types of fungus?

A: Yes, official microbiology sections detail the medicine's activity against various microorganisms. Studies have demonstrated its effectiveness against most isolates of specific fungi, including different species of Candida (e.g., C. albicans, C. tropicalis) and Cryptococcus neoformans.


Q: Does Fluconazol Olainfarm work for fungal infections in the nails?

A: Yes, Fluconazole is officially indicated for treating onychomycosis (fungal infections of the nails). This treatment is typically reserved for cases where other therapies are not deemed appropriate.


Q: Can Fluconazol Olainfarm affect cholesterol levels?

A: Official safety data confirms that fluconazole can, in uncommon cases, cause changes in blood lipids. Specifically, increases in blood levels of both serum triglycerides and cholesterol have been documented as possible adverse reactions.


Q: Is it normal to have mild abdominal pain when starting Fluconazol Olainfarm?

A: Yes, abdominal pain is listed in regulatory documents as a common adverse reaction, along with nausea, vomiting, and diarrhea. This means it is among the more frequently reported side effects, occurring in 1% to 10% of users in clinical studies.


Q: Are there any documented cases of resistance to Fluconazol Olainfarm?

A: Official microbiology information acknowledges that resistance to fluconazole has been documented in certain fungal species. For instance, the species C. krusei is considered inherently resistant, and some isolates of C. glabrata show intermediate susceptibility, as noted in regulatory product labeling.


Q: Does Fluconazol Olainfarm affect the effectiveness of blood thinners?

A: Yes, regulatory documents indicate a significant interaction with certain anticoagulants (blood thinners), such as warfarin. Fluconazole inhibits the liver enzymes that break down these medicines, which can lead to increased concentrations of the blood thinner in the body. The concurrent use of these combinations may necessitate dose adjustments or increased clinical monitoring.

Advertisements

How should Fluconazol Olainfarm be stored and disposed of?

Official Storage and Disposal Requirements

Fluconazole must be stored according to regulatory conditions to ensure stability. All dosage forms, including tablets and intravenous solutions, must be kept at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F).

Handling and Stability

Preparation Storage Requirement
Tablets / IV Solution Store at Controlled Room Temperature.
IV Solution / Suspension Must be protected from freezing.
Reconstituted Suspension Stable for 14 days when stored between 5°C and 30°C; must be discarded thereafter.

All forms must be kept in the original container, tightly closed, and stored out of the sight and reach of children.

Disposal: Unused or expired fluconazole must be disposed of in accordance with all local and national requirements. Disposal instructions explicitly state the need to avoid release to the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluconazol Olainfarm found in:

A-Z Index: